Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Physiol Behav ; 74(1-2): 29-35, 2001.
Article in English | MEDLINE | ID: mdl-11564448

ABSTRACT

Gender differences of feeding pattern in normal male and female rats are well recognized. Differences in gender-related feeding patterns have also been established following a variety of experimental manipulations, such as hypothalamic lesions, nicotine infusion, and total parenteral nutrition administration. Anorexia is a common feature during tumor growth. The present study examined whether the feeding indices constituting the feeding patterns differed with the development of cancer anorexia in male and female rats. Sixteen male and 15 female Fischer-344 rats had their food intake (FI) and feeding indices, meal number (MN) and meal size (MZ), continuously measured by a computerized rat eater meter. Viable methylcholanthrene (MCA) sarcoma cells (10(6)) were inoculated subcutaneously in 10 male (M-TB) and 8 female (F-TB) Fischer rats, while the rest were controls and received an equal volume of vehicle. Tumor-bearing (TB) rats became anorectic by Day 18, when the weight of the tumor was approximately 8% of the total body weight (BW). A notable decrease in BW was observed in both M-TB and F-TB. A decrease in FI resulted from different feeding indices between male and female rats. In male rats, lower FI was due to a decrease in both MN and MZ. In female rats, lower FI was solely due to a decrease in MN. The data show that gender differences in feeding patterns, which are an external manifestation of biochemical changes in the brain, occur following development of cancer-related anorexia suggesting that besides other factors, cancer anorexia is also influenced by sex-related hormones.


Subject(s)
Anorexia/psychology , Eating/physiology , Sarcoma, Experimental/psychology , Animals , Anorexia/etiology , Body Weight/drug effects , Brain Chemistry/drug effects , Estradiol/pharmacology , Estrus/physiology , Female , Male , Methylcholanthrene/pharmacology , Rats , Rats, Inbred F344 , Sarcoma, Experimental/complications , Sarcoma, Experimental/pathology , Sex Characteristics
2.
J Neurosci ; 19(24): 10886-97, 1999 Dec 15.
Article in English | MEDLINE | ID: mdl-10594070

ABSTRACT

The cancer-related event that is most disruptive to the cancer patient's quality of life is pain. To begin to define the mechanisms that give rise to cancer pain, we examined the neurochemical changes that occur in the spinal cord and associated dorsal root ganglia in a murine model of bone cancer. Twenty-one days after intramedullary injection of osteolytic sarcoma cells into the femur, there was extensive bone destruction and invasion of the tumor into the periosteum, similar to that found in patients with osteolytic bone cancer. In the spinal cord, ipsilateral to the cancerous bone, there was a massive astrocyte hypertrophy without neuronal loss, an expression of dynorphin and c-Fos protein in neurons in the deep laminae of the dorsal horn. Additionally, normally non-noxious palpation of the bone with cancer induced behaviors indicative of pain, the internalization of the substance P receptor, and c-Fos expression in lamina I neurons. The alterations in the neurochemistry of the spinal cord and the sensitization of primary afferents were positively correlated with the extent of bone destruction and the growth of the tumor. This "neurochemical signature" of bone cancer pain appears unique when compared to changes that occur in persistent inflammatory or neuropathic pain states. Understanding the mechanisms by which the cancer cells induce this neurochemical reorganization may provide insight into peripheral factors that drive spinal cord plasticity and in the development of more effective treatments for cancer pain.


Subject(s)
Bone Neoplasms/physiopathology , Neuronal Plasticity/physiology , Sarcoma, Experimental/physiopathology , Spinal Cord/physiopathology , Animals , Behavior, Animal , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/metabolism , Bone Neoplasms/pathology , Bone Neoplasms/psychology , Cell Division , Femur/diagnostic imaging , Femur/pathology , Mice , Mice, Inbred C3H , Mice, Inbred Strains , Neurons, Afferent/pathology , Pain/physiopathology , Palpation , Radiography , Sarcoma, Experimental/diagnostic imaging , Sarcoma, Experimental/metabolism , Sarcoma, Experimental/pathology , Sarcoma, Experimental/psychology , Spinal Cord/metabolism , Spinal Cord/pathology
3.
Brain Res ; 691(1-2): 180-4, 1995 Sep 11.
Article in English | MEDLINE | ID: mdl-8590051

ABSTRACT

Although isoproterenol stimulated adenylate cyclase activity in hypothalamic membranes taken from freely-feeding, food-restricted or nonanorectic tumor-bearing rats, the response was greatly reduced in anorectic tumor-bearing rats. The addition of NPY to the membrane preparation inhibited adenylate cyclase activity in hypothalamus taken from freely-feeding and food-restricted rats, but NPY-inhibitory activity was significantly reduced in both groups of tumor-bearing rats. These results suggest that cyclic AMP formation is refractory in anorectic tumor-bearing rats, and that NPY-induced inhibition of hypothalamic adenylate cyclase is reduced in tumor-bearing rats prior to the onset of significant anorexia. Therefore, NPY-induced feeding may be reduced in tumor-bearing organisms due to a dysfunction in the cyclic AMP second messenger system.


Subject(s)
Adenylyl Cyclases/drug effects , Anorexia/enzymology , Feeding Behavior/drug effects , Hypothalamus/drug effects , Isoproterenol/antagonists & inhibitors , Neuropeptide Y/pharmacology , Sarcoma, Experimental/enzymology , Analysis of Variance , Animals , Anorexia/etiology , Anorexia/psychology , Cyclic AMP/biosynthesis , Hypothalamus/enzymology , Male , Rats , Rats, Inbred F344 , Sarcoma, Experimental/complications , Sarcoma, Experimental/psychology
SELECTION OF CITATIONS
SEARCH DETAIL
...